EP Patent

EP3771467A1 — Ss-31 for the prevention and/or treatment of aneurysm

Assigned to Consejo Superior de Investigaciones Cientificas CSIC · Expires 2021-02-03 · 5y expired

What this patent protects

The present invention relates to SS-31 or composition comprising SS-31 for use in the treatment and/or prevention of aneurysm.

USPTO Abstract

The present invention relates to SS-31 or composition comprising SS-31 for use in the treatment and/or prevention of aneurysm.

Drugs covered by this patent

elamipretide-hydrochloride (ELAMIPRETIDE HYDROCHLORIDE)

Patent Metadata

Patent number: EP3771467A1
Jurisdiction: EP
Classification: —
Expires: 2021-02-03
Drug substance claim: No
Drug product claim: No
Assignee: Consejo Superior de Investigaciones Cientificas CSIC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.